Abstract
Both Canada and the United States have advanced medical care systems, and in both countries the COVID-19 pandemic has had a major impact on population health and the economy. The similarities and differences between the two countries’ healthcare systems have made cross-national comparisons an important source of insight into the strengths and weaknesses of their respective health systems (1). During the COVID-19 pandemic, both COVID-19 cases and deaths per capita have been higher in the United States than in Canada, while decline in gross domestic product has been 2.1% greater in Canada than in the U.S. (2). Greater economic losses in Canada may reflect more aggressive use of non-pharmaceutical measures such as business and school closures to reduce disease transmission. Per capita attack rates and deaths seen in the United States represent a counterfactual, which Canada might have experienced with less aggressive disease control measures.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The research was supported by a grant to DNF from the Canadians Institutes for Health Research (2019 COVID-19 rapid researching funding OV4-170360).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This specific piece of work is IRB exempt (data are in the public domain) but work done under approval by the University of Toronto Research Ethics Board for COVID-19 research by the Ontario Modelling Table.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
The research was supported by a grant to DNF from the Canadians Institutes for Health Research (2019 COVID-19 rapid researching funding OV4-170360).
Data Availability
All data used for analyses are publicly available. A link to data files is included in the manuscript.
